Obesity is often associated with high systemic and local activity of renin-angiotensin system (RAS). Mesenchymal stem cells of adipose tissue are the main source of adipocytes. The aim of this study was to clarify how local RAS could control adipose differentiation of human adipose tissue derived mesenchymal stem cells (ADSCs). We examined the distribution of angiotensin receptor expressing cells in human adipose tissue and found that type 1 and type 2 receptors are co-expressed in its stromal compartment, which is known to contain mesenchymal stem cells. To study the expression of receptors specifically in ADSCs we have isolated them from adipose tissue. Up to 99% of cultured ADSCs expressed angiotensin II (AngII) receptor type 1 (AT1). Using the analysis of Ca 2+ mobilization in single cells we found that only 5.2 ± 2.7% of ADSCs specifically respond to serial Ang II applications via AT1 receptor and expressed this receptor constantly. This AT1
Introduction
Renin-angiotensin system (RAS) was initially described as a hormonal circuit controlling body electrolyte balance and blood pressure (Campbell, 1987; Ribeiro et al., 1985) . Angiotensinogen produced by liver is cleaved by kidney-synthesized renin to a decapeptide angiotensin I, which is further processed by endothelial angiotensin-converting enzyme (ACE) to angiotensin II (Ang II). Predominant target of Ang II in adult tissues is type 1 receptor (AT1), expressed by many cell types, including endothelial and smooth muscle cells. AT1 is a seven-domain transmembrane receptor, which initiates many intracellular signaling cascades including Ca 2+ mobilization. As a net result Ang II causes blood vessel wall contraction and increases the blood pressure (Dinh et al., 2001) . Ang II also causes inflammation and fibrosis in AT 1 -dependent manner (Brasier et al., 2002; Linz et al., 1995; Mezzano et al., 2001) . Besides AT1, cells could also express type 2 angiotensin receptor (AT2). Ang II binding to AT2 is thought to counterbalance negative effects triggered by AT1, since it causes anti-inflammatory, antifibrotic response (Dinh et al., 2001; Horiuchi et al., 2012) . Despite in embryogenesis both AT1 and AT2 are highly expressed, the presence of AT2 declines soon after birth (Lazard et al., 1994; Shanmugam and Sandberg, 1996) . As a beneficial system, counteracting detrimental effects of Ang II/AT1 axis, "alternative angiotensin peptides" could be produced, including angiotensin 1-7 and alamandine, which interact to MAS1 and MrgD receptors (reviewed in Carey, 2013; Etelvino et al., 2014) . Together with circulating RAS, a local production of angiotensinogen and its processing enzymes was found in several organs, including kidney, brain, heart, pancreas and adipose tissue (Campbell, 1987; Cassis et al., 2008; Danser, 1996) . Ang II production by adipocytes increases during pathologies associated with obesity (Engeli et al., 2000; Henriksen et al., 2001) . Its significance for adipose tissue growth and metabolism is intensively studied. The main precursors for adipocytes are mesenchymal stem cells of adipose tissue (ADSCs) (Hausman et al., 2001; Pittenger, 1999; Scavo et al., 2004) , and adipose tissue hyperplasia seems to depend on the adipogenic potency of ADSCs and their further differentiation to adipocytes.
In this study we demonstrated that type 1 and type 2 receptors are co-expressed in the stromal compartment of human adipose tissue. The majority of ADSCs isolated from subcutaneous fat expressed AT1 receptor. Among these cells we found a subpopulation with increased adipose competency, which was triggered by endogenous AngII.
Inhibitory and expression analyses showed that these ADSCs highly coexpressed AT2 receptor, which was responsible for increased adipose competency of this ADSC subpopulation.
Material and methods

Immunofluorescent detection of angiotensin receptors in situ
Subcutaneous fat tissue was obtained from 18 donors during abdominal surgery. All donors gave their informed consent and the local ethics committee of city clinical hospital #31 (Moscow, Russia) approved the study protocol. Average donor's BMI was 23.5 ± 2.4, they did not have acute inflammation, diabetes or oncological diseases. Part of each sample was placed in O.C.T. Compound (Sakura Inc., Tokyo, Japan) and frozen in liquid nitrogen for immunofluorescent analysis. Other part of each sample was used for ADSC isolation (see below). Angiotensin receptors were visualized by immunofluorescent staining of 10 μm frozen sections using antibodies against AT1 receptor (PA5-20812, ThermoFisher Scientific, dilution 1:100), AT2 receptors (Rabbit polyclonal to AT2 Alomon), Mas receptor (Rabbit polyclonal to MAS1 antibody ab66030, Abcam). Briefly, sections were fixed in 4% paraformaldehyde for 10 min. After several washes by phosphate buffer saline (PBS) sections were incubated in 0.1% bovine serum albumine (BSA) containing 10% normal donkey serum to block non-specific binding of antibodies. This was followed by incubation with specific primary antibodies, for 1 h and subsequent extensive washing in PBS. Then sections were incubated with Alexa594-conjugated donkey anti-rabbit (Molecular Probes). To assess the co-localization of cells expressing AT1 receptor and blood vessels, we performed double immunofluorescent staining: sections were incubated with mix of antibodies against AT1 receptor and mouse CD31 antibodies (BD Pharmingen) to endothelial cells. This was followed by incubation with Alexa594-conjugated donkey anti-rabbit antibody and Alexa488-conjugated anti-mouse antibody (Molecular Probes). Cell nuclei were counterstained with DAPI (Molecular Probes), and sections were mounted in Aqua Poly/Mount (Polysciences Inc). For negative controls mouse or rabbit non-specific IgGs were used in appropriate concentration. Images were obtained using confocal microscope LSM 780 and ZEN2010 software (Zeiss).
ADSCs isolation and culturing
ADSCs were isolated from subcutaneous fat tissue using enzymatic digestion as previously described (Zuk et al., 2001) . Cells were cultured in Mesenchymal Stem Cell Basal Medium (HyClone, GE Healthcare Life Sciences, USA) containing 10% AdvanceSTEM Supplement (HyClone, GE Healthcare Life Sciences, USA), 1% antibiotic-antimycotic solution (HyClone, GE Healthcare Life Sciences, USA) at 37°C in 5% CO 2 incubator. Cells were passaged at 70% confluency using HyQTase Cell Detachment Reagent (HyClone, GE Healthcare Life Sciences, USA). For the experiments, ADSCs cultured up to 2rd-5th passages were used. To confirm their multipotency and specific immunophenotype, ADSCs were induced into osteogenic, adipogenic and chondrogenic differentiation and characterized by the expression of CD45, CD73, CD90, CD105 markers as described earlier (Dzhoyashvili et al., 2014) .
Flow cytometry and fluorescence-activated cell sorting (FACS)
The proportion of ADSCs expressing Ang II receptors, their immunophenotype and ACE expression were analyzed using flow cytometry. Cells were detached from culture dishes using HyQTase Detachment Reagent (HyClone, GE Healthcare Life Sciences, USA) and stained with antibodies in appropriate combinations. AT1 receptors were detected using specific antibodies AT1 (PA5-20812, ThermoFisher Scientific, dilution 1:100), following by secondary antibodies DyLight 488 Jackson Immunoresearch, 1:300) were measured in individual cells using fluorescent microscope Nikon Eclipse Ti (objective 10 ×) equipped with camera Andor iXon 897 (Andor Technology). Movies were analyzed using NIS-Elements (Nikon) and ImageJ software. Alterations of cytosolic Ca 2+ from the resting level were quantified as a difference of Fluo-8 fluorescence intensity (ΔF/F 0 ) recorded from an individual cell.
RNA isolation and quantitative RT-PCR
Total RNA was isolated and purified using the Quick-RNA™ MicroPrep (Zymo Research, USA) according to the manufacturer's instructions. On-column DNase digestion of samples was performed. The RNA was quantified and qualified using Nanodrop spectrophotometer (Thermo Scientific, USA). The total RNA samples with the 260/ 280 nm ratio of 1,9 to 2,1 were used for further analyses. The first strand cDNA was synthesized with the SuperScript ® III First-Strand Synthesis System (Life Technologies, USA) using Oligo(dT) 20 primers according to the manufacturer's instructions. The quantitative real-time PCR (RTqPCR) was performed in the 96-well plates in a DT-96 Real-time cycler (DNA-Technology, Russia) with qPCRmix-HS SYBR (Evrogen, Russia) and 10 μM of specific primers (or 5 μM for REN, CEBPβ). The thermocycling of each sample was performed in triplicates using the following conditions: 94°C for 3 min, followed by 40 cycles of 94°C for 10 s, 60°C (or 64°C for REN, CEBPβ) for 10 s and 72°C for 20 s. The RealTime_PCR v7.0 software (DNA-Technology, Russia) was used for the data analysis. Expression levels of the genes were calculated relative to RPL13A levels by the comparative ΔC T method. The following primers were used for RT-qPCR: AGT (NM_000029), 176 bp, forward 
Adipogenic differentiation
ADSCs subpopulations isolated by FACS were cultured in Mesenchymal Stem Cell Basal Medium until confluency and differentiated using AdvanceSTEM adipogenic differentiation medium (HyClone, GE Healthcare Life Sciences, USA) with medium refresh two times a week. mRNA levels of adipose differentiation master-genes were evaluated 7 days after the differentiation start. Accumulation of intracellular lipids was visualized after 21 days of differentiation by Oil-Red-O (Merck Millipore, USA) and Mayer's hematoxylin (Dako, USA) staining according the manufacturer's instructions. Stained cells were analyzed using Leica DMI6000B microscope equipped with DFC420 C camera. Portions of cells with bright fat droplets were counted in 10 random fields of view (objective 10×) with MetaMorph 5.0 software (Universal Imaging). Treatment of the cells with Ang II or RAS inhibitors was performed every differentiation medium refresh. The following chemicals were used: Ang II (ab120183, Abcam, 10 nM), ACE inhibitor enalaprilat (ab142866, Abcam, 10 μM), AT1 receptor inhibitor losartan (ab120997, Abcam, 1 μM), AT2 receptor inhibitor PD123319 (1361, Tocris, 1 μM). 
Statistics
All experiments were repeated at least three times. Statistical analysis was performed using SigmaPlot 12.5 software. The data was assessed for normality of distribution using the Shapiro-Wilk test. Comparison of independent groups was performed by Kruskal-Wallis one way analysis of variance on ranks with subsequent application of Student-NewmanKeuls or Dunn's method. Statistical significance was defined as P-value b 0.05. Values are expressed as mean ± standard error of mean (s.e.m.)
Results
Expression and activity of angiotensin receptors in adipose tissue ADSCs
The expression of angiotensin receptors in adipose tissue of nonobese humans was examined using immunofluorescence and confocal microscopy. AT1 receptor was found in the most of cells within adipose tissue, including CD90-positive stromal cells and blood vessels (Fig. 1A) . AT1 expression was also detected in PDGF receptor beta-positive cells and in subendothelial cells (see Figs. 1 and 2 in (Ageeva et al., 2017) ). As for AT2 receptor, it was found in adipocytes as well as CD90-expressing stromal cells (Fig. 1B) . Adipose tissue also contained expressing MAS1 receptor (see Fig. 3 in (Ageeva et al. 2017) ). Tissue location, morphology and surface markers of cells expressing angiotensin receptors match those of ADSCs, therefore suggesting that these cells could be controlled by angiotensin peptides in vivo.
To evaluate the expression of receptors specifically in ADSCs we isolated these cells from adipose tissue and examined the expression of angiotensin receptors using flow cytometry and immunofluorescent staining of cultured cells. In agreement with in situ data, 99% of isolated ADSCs of 2nd to 5th passage expressed AT1 receptor ( Fig. 2A) . Proportions of cells expressing AT2 receptors were much lower and varied substantially between different donors (Fig. 2B and Table in (Ageeva et al., 2017) ). To exclude the possibility that receptors were detected on cells other than ADSCs we performed a co-staining with ADSC markers (CD73, CD90, CD105, CD45) and AT1 receptor. All AT 1 + ADSCs were CD45 − , 99.9 ± 0.1% were CD90 + , 96.7 ± 2% -CD73 + CD105 + (Fig.   2C ). We further confirmed the presence of AT1 and AT2 receptors on cultured ADSCs by immunofluorescence (Fig. 2D,E) . To determine if AT1 receptors expressed on ADSCs are active we treated ADSCs with Ang II and registered intracellular Ca 2+ influx in individual cells using fluorescent calcium binding dye Fluo-8. We showed that 48.5 ± 9.7% of ADSCs specifically respond to a single Ang II application and AT1 receptor antagonist losartan inhibits these responses (Movie S1). Thus, AT1 receptors on ADSCs are functionally active. However, only 5.2 ± 2.7% of cells responded not to single but serial Ang II applications (Movie S1). This indicated that in the most of ADSCs AT1 undergoes rapid internalization upon ligand binding. Indeed, when we provoked receptor internalization by incubating cells with antibodies against AT1 at the room temperature instead of + 4°C, only 2.8 ± 0.9% of cells were positively stained for AT1 receptor (see Fig. 5 in (Ageeva et al., 2017) ). The proportion of cells expressing AT2 did not change after staining at room temperature.
ADSCs with constant expression of AT1 receptor differentiate to adipocytes more efficiently
According to the literature, Ang II is able to suppress adipose differentiation of cultured ADSCs Matsushita et al., 2006) . Indeed, Ang II delayed the expression of adipose differentiation marker genes in cultured ADSCs (Fig. 3A) . This allowed us to hypothesize that subpopulation of ADSCs constantly expressing AT1 receptor would demonstrate delayed or blocked adipose differentiation. To examine this we isolated a subpopulation of ADSCs constantly expressing AT1 receptors (AT1 const ) using FACS. We induced their adipose differentiation without adding exogenous Ang II and found that these cells differentiated towards adipocytes more rapidly (Fig. 3B, C) . Thus, after 7 days of incubation in adipogenic differentiation medium the mRNA content of early adipose differentiation master-genes -CEBPβ, Klf5 and late genes -PPARγ and adiponectin, was significantly higher in AT1 const ADSCs than in other cells in the population (Fig. 3B) . Furthermore, after 21 days incubation the portion of cells with bright fat droplets was significantly higher among AT1
const ADSCs (Fig. 3C ).
Increased differentiation efficiency of AT1 const cells could be a consequence of their predisposal to adipose differentiation due to the intrinsic high expression of adipocyte master-genes. To clarify this issue we compared the content of CEBPβ, Klf5 and PPARγ mRNAs in AT1 const and AT1-negative ADSCs subpopulations before the incubation in adipogenic differentiation medium. There were no significant differences between examined mRNAs (Fig. 3D) . Therefore AT1 const ADSCs
were not initially committed to adipose differentiation. Variance in the differentiation efficiency in the absence of exogenous Ang II suggests that the endogenous production of angiotensinogen and angiotensin peptides by AT1 const ADSCs or expression of angiotensin receptors in these cells differ from AT1-negative ADSCs.
AT1 const ADSCs co-express other angiotensin receptors and RAS components
We examined the production of angiotensin peptides and expression of angiotensin receptors in AT1
const ADSCs and other cells in the population using quantitative RT-PCR and flow cytometry. The content of mRNAs of angiotensinogen (AGT) and enzymes generating Ang II and Ang 1-7, including renin (REN), ACE and angiotensinase C (PRCP) as well as the cell surface ACE expression did not differ between AT1 const ADSCs and other cells in the population (Fig. 4A,C) . However, the expression of angiotensin receptors, including AT1, AT2, MAS1 and MrgD was higher comparing to other cells in the population (4.4 ± 0.6 folds for AT1, 11.3 ± 5.5 folds for AT2, 7.1 ± 1.6 -MAS and 9 ± 2.3 -MrgD) (Fig. 4B) . Furthermore, flow cytometry demonstrated that AT2 receptor was predominantly expressed on AT1 const ADSCs rather than on the other cells in the population (Fig. 6 in (Ageeva et al., 2017) ).
These data indicate that all examined ADSCs express RAS components, but only AT1 const cells contain other angiotensin receptors including AT2, which could be responsible for increased efficiency of adipose differentiation of these cells. 
Endogenous RAS is involved in the control of ADSC adipose differentiation
To confirm that endogenously produced AngII is involved in the control of adipose differentiation of ADSCs, we incubated cells in adipogenic differentiation medium in the presence of ACE inhibitor enalaprilat. Cell treatment with enalaprilat increased the expression of adipocyte markers, including adiponectin and PPARγ (Fig. 5 ). Cell treatment with AT1 inhibitor losartan also led to the stimulation of adipose differentiation, whereas AT2 inhibitor PD123319 inhibited the expression of adipocyte markers. The magnitude of this inhibition appeared to positively correlate with a proportion of AT2-expressing cells in the population (see Table in (Ageeva et al., 2017) ).
Taken together, our data indicate that human ADSCs contain a subpopulation of cells with increased adipogenic potency. This subpopulation is labeled by high co-expression of angiotensin receptors. Increased adipogenic potency of ADSCs highly co-expressing angiotensin receptors is caused by their ability to respond to endogenously produced AngII via AT2.
Discussion
Despite renin-angiotensin-aldosterone system has been studied for a long time, its role in various physiological and pathological processes still attracts close attention, first of all because pharmacological instruments for influencing RAS activity in humans are accumulated. In this study we demonstrated the expression of angiotensin receptors in stromal compartment of human adipose tissue in situ. Specifically, our data indicate that ADSCs of adipose tissue stroma demonstrate a heterogeneous expression of angiotensin receptors and produce angiotensinogen together with enzymes necessary for angiotensin peptides generation. These data advance previous observations that angiotensinogen is one of adipokines produced by pre-adipocytes and mature adipocytes, which expression increases with lipids accumulation (Safonova et al., 1997) . Also, these data confirm previous findings obtained in ADSC lines Matsushita et al., 2006) Liu et al., 2015) . Here we showed that exogenous and endogenous Ang II influence adipose differentiation of ADSCs. In line with previous observations (Brucher et al., 2007; Janke et al., 2006 Janke et al., , 2002 our data indicate that Ang II inhibits adipose differentiation acting via AT1 receptor. For a first time here we report that ADSCs contain a subpopulation of cells constantly expressing AT1. These cells appeared to co-express AT2 receptor together with receptors for alternative angiotensin peptides. AT1 const demonstrate the increased adipogenic differentiation in response to local RAS, which can be suppressed by AT2 inhibitor. Our in situ data demonstrate that in adipose tissue cells expressing AT2 receptor are predominately located at sites of increased cellularity between mature adipocytes. Such sites are often occupied by so-called angio-adipogenic clusters, responsible for expansion of adipose tissue during obesity (Kalinina et al., 2009) . In contrast to previous reports, suggesting that AT1-dependent signaling dominates in adult cells co-expressing AT1 and AT2 receptors, our data indicate that ADSCs highly expressing angiotensin receptors respond predominately via type 2 receptor. These data allow us to suggest that this subpopulation of ADSCs retains embryonic RAS signaling, which correlates with our previous findings that ADSCs preserve embryonic adrenergic signaling regulation (Tyurin-Kuzmin et al., 2016) . Possibly, AT1-dependent signaling could be suppressed by heteromerization with АТ2, as was previously demonstrated (AbdAlla et al., 2001; Yang et al., 2012) .
ADSCs isolated from adipose tissue are considered as the one of the most promising material for regenerative medicine. The presence in their population of cells with high "adipose competency" such as ones constantly expressing angiotensin receptors should be taken into consideration since these cells could be a source of spontaneous adipose tissue formation at sites of transplantation. Importantly, ADSCs of such phenotype could contribute to ectopic adipogenesis often observed during various pathologies.
Conclusions
Our data indicate that human adipose tissue contains a subpopulation of ADSCs constantly co-expressing AT1 and AT2 angiotensin receptors. These cells demonstrate increased adipose competency, which is caused by their response to autocrine Ang II via AT2 receptor.
Supplementary data to this article can be found online at https://doi. org/10.1016/j.scr.2017.10.022.
